Información del producto
MS417 is a potent antagonist of the protein erythropoietin receptor and has shown to be effective in the treatment of tumor cells. The drug binds to the erythropoietin receptor, blocking the signal transduction pathway that leads to cell proliferation. MS417 has been shown to inhibit tumor growth in an experimental model and is currently being tested in clinical trials for cardiac dysfunction and treatment of HIV infection. It also inhibits the production of histones proteins that are involved in epigenetic regulation of gene expression.
Propiedades químicas
Consulta técnica sobre: 3D-RLB48936 MS417
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
